Cargando…
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial
INTRODUCTION: Previous studies have suggested that more intensive initial therapy for hypertension results in better long-term blood pressure (BP) control. We test this hypothesis comparing initial monotherapy with dual therapy in the management of essential hypertension. METHODS AND ANALYSIS: The s...
Autores principales: | MacDonald, Thomas M, Williams, Bryan, Caulfield, Mark, Cruickshank, J Kennedy, McInnes, Gordon, Sever, Peter, Webb, David J, Mackenzie, Isla S, Salsbury, Jackie, Morant, Steve, Ford, Ian, Brown, Morris J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539389/ https://www.ncbi.nlm.nih.gov/pubmed/26253566 http://dx.doi.org/10.1136/bmjopen-2015-007645 |
Ejemplares similares
-
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension
por: Brown, Morris J, et al.
Publicado: (2015) -
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial
por: MacDonald, Thomas M., et al.
Publicado: (2017) -
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension
por: Williams, Bryan, et al.
Publicado: (2015) -
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
por: Williams, Bryan, et al.
Publicado: (2015) -
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
por: Brown, Morris J, et al.
Publicado: (2016)